Australia Markets closed

Company News For Sep 4, 2019

Zacks Equity Research
  • Conn's, Inc.’s CONN shares rose 18.3% after the company reported second quarter fiscal 2020 earnings per share of $0.62, surpassing the Zacks Consensus Estimate of $0.51
  • The Medicines Company’s MDCO shares gained 10.4% after the company reported positive results from its ORION-11 trial at ESC Congress 2019.
  • Shares of Emergent BioSolutions Inc. EBS surged 14.5% after the company received a 10-year HHS contract to provide ACAM2000 smallpox vaccines to the U.S. Strategic National Stockpile
  • Shares of Royal Caribbean Cruises Ltd. RCL fell 1.4% afterthe reorts surfaced that the company could suffer losses of up to $0.05 a share in the current quarter due to the impact of Hurricane Dorian


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report
 
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
 
The Medicines Company (MDCO) : Free Stock Analysis Report
 
Conn's, Inc. (CONN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research